For the 2019 Management of Non-Neurogenic Male LUTS Guidelines, new and relevant evidence has been identified, collated and appraised through a structured assessment of the literature. A broad and comprehensive literature search, covering all sections of the Non-Neurogenic Male LUTS Guidelines was performed. The search was limited to studies representing high levels of evidence, i.e. systematic reviews with meta-analysis, randomised controlled trials (RCTs), and prospective non-randomised comparative studies, published in the English language. As a result of the scoping search additional references and text updates have been incorporated throughout the 2019 version of the Non-Neurogenic Male LUTS Guidelines. Specific changes include:
Chapter 5.3 Surgical treatment
- Transurethral microwave therapy (TUMT) and transurethral needle ablation of the prostate (TUNA) have been removed from the Guidelines. Information on to both of these techniques may now be found in the Non-Neurogenic Male LUTS Guidelines Supplementary Online Material.
- Section 5.3.7 Techniques under investigation has replaced section 5.3.8 Novel Interventions from the 2018 Guidelines. Section 5.3.7 addresses: Minimal invasive simple prostatectomy; (i)TIND; Aquablation – image guided robotic waterjet ablation; Convective water vapour energy (WAVE) ablation; and Prostatic artery embolization.
Chapter 5.5 Management of Nocturia in men with lower urinary tract symptoms
- The recommendations relating to the use of desmopressin for the treatment of nocturia have been revised following a structured assessment of the available evidence.